Response to hepatitis B vaccination in patients with liver cirrhosis
Citations Over TimeTop 17% of 2017 papers
Abstract
Hepatitis B vaccination is strongly recommended for all infants and children but also for adults who are at risk of HBV infection. Attempts to immunize patients with liver cirrhosis have been proven relatively ineffective, and several strategies have already been used to improve the immune response in this group. The primary aim of this review is to examine, discuss, and summarize the immunogenicity of hepatitis B vaccination in patients with liver cirrhosis. MEDLINE search identified 11 studies (n = 961). The dose of the vaccine and the schedule of the vaccination varied. The response rates to the HBV vaccination ranged from 16% to 87% among patients with cirrhosis regardless of the number and vaccine dose. In particular, patients who received the standard dose of vaccination achieved seroprotection rates ranged from 16% to 79% (mean response rate 38%) and those who received a double dose achieved relatively better seroprotection rates (range: 26%-87%; mean response rate 53%). The overall mean response rate to the HBV vaccination was 47%. In conclusion, cirrhotic patients achieve lower seroprotection rates after the completion of HBV vaccination series. Several strategies have tried to improve the immunogenicity; however, there is a great need for additional studies to further explore (1) the immune response in relation to poor vaccination responsiveness confounding factors, (2) novel strategies to improve immunogenicity, and (3) the immune mechanism underlying the differences in response rates to HBV vaccination.
Related Papers
- → Safety and immunogenicity of an inactivated hepatitis A candidate vaccine in healthy adult volunteers(1990)85 cited
- Study on thymosin and booster dosage of hepatitis B vaccine inducing specific immune response against HBsAg in nonresponders to hepatitis B vaccination(2012)
- Observation on immunogenicity of different formulation of hepatitis B vaccine in newborns(2014)
- Immune Effect of Hepatitis A and B Combined Vaccine in Adults without Response to Hepatitis B Vaccine(2007)
- The immunogenicity and safety study of concurrent hepatitis A and hepatitis B vaccination in recruits(2004)